It’s easy to spot motivated and engaged employees. They are more productive, they go the extra mile, and they display a sense of ownership in their work.But how do you replicate this culture throughout your organization? How do you encourage…
HOME > BUSINESS
BUSINESS
- Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
October 25, 2018
- Swiss API Manufacturer Bachem Establishes Japanese Subsidiary
October 25, 2018
- GSK to Cover Cost of Rubella Testing and Vaccination for Employees
October 25, 2018
- AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
October 24, 2018
- Meiji Seika Pharma Files Safinamide for Parkinson’s Disease in Japan
October 24, 2018
- Regenerative Medicine Product Market to Reach 225 Billion Yen in 2030: Fuji Keizai
October 24, 2018
- Parexel CEO Sees Bright Future for Japan CRO Market
October 23, 2018
- DS-8201 Shows Overall Response Rate of 15.8% in Patients with Colorectal Cancer in Japan-US PI Study: Daiichi Sankyo
October 23, 2018
- Hisamitsu Begins Japan PII Study of Hyperhidrosis Treatment
October 23, 2018
- Eisai, MSD Begin Joint Information Provisioning for Lenvima in Japan
October 23, 2018
- Mitsubishi Tanabe Teams Up with Bioventure for Novel Antibody Drug Discovery Research in Autoimmune Diseases
October 23, 2018
- Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
October 22, 2018
- Daiichi Sankyo Begins 1st-in-Human Trial for AXL Inhibitor
October 22, 2018
- JCR’s Hunter Syndrome Drug Grabs FDA’s Orphan Status
October 22, 2018
- Eisai, Keio Univ. Identify Candidate Compound for Parkinson’s Disease Employing iPS Cells
October 22, 2018
- Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand
October 19, 2018
- Takeda Earns Japan Clearance for Shire Acquisition
October 19, 2018
- Asahi Kasei Obtains Patent License for iPS Cell-Derived Cartilage Regeneration Technology
October 18, 2018
- Sumitomo Dainippon to Invest in, Conduct Joint R&D with Cyborg Tech Startup
October 18, 2018
- Nippon Shinyaku Seeks Japan Approval for Hepatic VOD Treatment Defibrotide
October 18, 2018
ページ
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…